Works matching IS 17569966 AND DT 2021 AND VI 40
Results: 428
Correction to: HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p/TGIF1/TGFβ axis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Retraction Note: MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: YPEL3 suppresses epithelial–mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Retraction Note: TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02210-3
- By:
- Publication type:
- Article
HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02188-y
- By:
- Publication type:
- Article
Correction to: Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02187-z
- By:
- Publication type:
- Article
Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02207-y
- By:
- Publication type:
- Article
Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02199-9
- By:
- Publication type:
- Article
Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02202-3
- By:
- Publication type:
- Article
The IRF2/CENP-N/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02191-3
- By:
- Publication type:
- Article
DISE/6mer seed toxicity-a powerful anti-cancer mechanism with implications for other diseases.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02177-1
- By:
- Publication type:
- Article
ZIP10 is a negative determinant for anti-tumor effect of mannose in thyroid cancer by activating phosphate mannose isomerase.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02195-z
- By:
- Publication type:
- Article
Correction to: USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02184-2
- By:
- Publication type:
- Article
Correction to: Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Regulation of the adaptation to ER stress by KLF4 facilitates melanoma cell metastasis via upregulating NUCB2 expression.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02193-1
- By:
- Publication type:
- Article
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02185-1
- By:
- Publication type:
- Article
Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02153-9
- By:
- Publication type:
- Article
Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02150-y
- By:
- Publication type:
- Article
Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02192-2
- By:
- Publication type:
- Article
Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02179-z
- By:
- Publication type:
- Article
Correction to: Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02176-2
- By:
- Publication type:
- Article
Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02186-0
- By:
- Publication type:
- Article
Correction to: Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
TMPRSS4 promotes cancer stem–like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02147-7
- By:
- Publication type:
- Article
Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02173-5
- By:
- Publication type:
- Article
Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02164-6
- By:
- Publication type:
- Article
Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02152-w
- By:
- Publication type:
- Article
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02148-6
- By:
- Publication type:
- Article
Correction to: LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02154-8
- By:
- Publication type:
- Article
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02166-4
- By:
- Publication type:
- Article
SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02162-8
- By:
- Publication type:
- Article
CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02149-5
- By:
- Publication type:
- Article
STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02116-0
- By:
- Publication type:
- Article
Retraction Note: A positive feedback loop consisting of C12orf59/NF-κB/CDH11 promotes gastric cancer invasion and metastasis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02159-3
- By:
- Publication type:
- Article